20 results
D
CRNX
Crinetics Pharmaceuticals Inc
11 Mar 24
$350.00 mm in equity, sold $350.00 mm, 36 investors
4:15pm
Energy
Coal Mining
Electric Utilities
Energy Conservation
Environmental Services
Oil & Gas
Other Energy
Health Care
Biotechnology
Health … Insurance
Hospitals & Physicians
Pharmaceuticals
Other Health Care
Manufacturing
Real Estate
Commercial
Construction
REITS & Finance
8-K
EX-10.1
CRNX
Crinetics Pharmaceuticals Inc
1 Mar 24
Crinetics Pharmaceuticals Announces Oversubscribed $350 Million Private Placement
4:07pm
Compliance with Health Care Laws. Except as described in the Recent SEC Filings, the Company and its subsidiaries are in compliance with all Health Care Laws … , “Health Care Laws” means: (i) the FDCA; (ii) all applicable federal, state, local and foreign health care fraud and abuse laws, including, without
8-K
EX-1.1
CRNX
Crinetics Pharmaceuticals Inc
13 Sep 23
Crinetics Pharmaceuticals Announces Proposed Public Offering of Common Stock
5:23pm
with the design and implementation of such trials.
(cc) Compliance with Health Care Laws. Except as described in the Registration Statement … , the Pricing Disclosure Package and the Prospectus, the Company and its subsidiaries are in compliance with all Health Care Laws except where failure to be so
8-K
EX-99.1
CRNX
Crinetics Pharmaceuticals Inc
13 Oct 22
Enrollment Completed in Phase 3 PATHFNDR-1 Study Evaluating Oral Paltusotine for the Treatment of Acromegaly
8:32am
to a health care provider’s office.”
Scott Struthers, Ph.D., founder and chief executive officer of Crinetics added, “The over-enrollment of the Phase 3
8-K
EX-1.1
wluem7yr5f5zm9qlospr
13 Apr 22
Crinetics Pharmaceuticals Announces Pricing of Underwritten Common Stock Offering
4:26pm
8-K
EX-1.1
3ziwrfpkt nfy
21 Oct 21
Crinetics Pharmaceuticals Announces Proposed Public Offering of Common Stock
4:24pm
8-K
EX-1.1
gcq21t
8 Apr 21
Crinetics Pharmaceuticals Announces Pricing of Public Offering of Common Stock
4:09pm
8-K
EX-1.1
yatcipujp ih
15 Apr 20
Crinetics Pharmaceuticals Announces Proposed Public Offering of Common Stock
4:06pm
S-3
EX-1.2
zw0ty xjqmirdj2
13 Aug 19
Shelf registration
4:36pm
10-K
ti0 55rxr
13 Mar 19
Annual report
4:06pm
424B4
xdl7sgl
18 Jul 18
Prospectus supplement with pricing info
5:27pm
S-1/A
EX-1.1
lv5shg1n3li7ojhxy8
9 Jul 18
IPO registration (amended)
6:10am
S-1/A
qus7u
9 Jul 18
IPO registration (amended)
6:10am
S-1
ef5ab95m83 ric
22 Jun 18
IPO registration
4:07pm
DRS/A
i3dydiex
11 Jun 18
Draft registration statement (amended)
12:00am
DRS
cr16 2tq7ghcn
3 May 18
Draft registration statement
12:00am
- Prev
- 1
- Next